https://news.medxy.ai/zh/body-composition-metrics-for-prognostication-in-head-and-neck-cancer-radiotherapy/Medxy AIzh2026-10-22T07:29:05-07:00整合身体成分指标用于头颈癌放射治疗的预后评估：进展与临床意义 https://news.medxy.ai/ja/integrating-body-composition-metrics-for-prognostication-in-head-and-neck-cancer-radiotherapy/Medxy AIja2026-10-22T07:28:42-07:00頭頸部がん放射線治療における予後予測のための身体組成指標の統合：進歩と臨床的意義 https://news.medxy.ai/vi/body-composition-radiotherapy-forecasting/Medxy AIvi2026-10-22T07:28:14-07:00Tích hợp các chỉ số thành phần cơ thể trong tiên lượng xạ trị ung thư đầu và cổ: Tiến bộ và ý nghĩa lâm sàng https://news.medxy.ai/integrating-body-composition-metrics-for-prognostication-in-head-and-neck-cancer-radiotherapy-advances-and-clinical-implications/Medxy AIen2026-10-22T07:27:48-07:00Integrating Body Composition Metrics for Prognostication in Head and Neck Cancer Radiotherapy: Advances and Clinical Implications https://news.medxy.ai/zh/optimizing-gastric-cancer-treatment/Medxy AIzh2026-10-22T07:26:55-07:00腹膜细胞学阳性或局限性腹膜转移胃癌的治疗策略优化 https://news.medxy.ai/ja/optimizing-gastric-cancer-treatment-2/Medxy AIja2026-10-22T07:26:37-07:00腹膜細胞診陽性・局所性腹膜転移を伴う胃癌の治療戦略最適化 https://news.medxy.ai/vi/gastric-cancer-treatment-strategy/Medxy AIvi2026-10-22T07:26:16-07:00Tối ưu hóa chiến lược điều trị ung thư dạ dày có tế bào học phúc mạc dương tính hoặc di căn phúc mạc khu trú https://news.medxy.ai/optimizing-treatment-strategies-for-gastric-cancer-with-positive-peritoneal-cytology-or-localized-peritoneal-metastasis/Medxy AIen2026-10-22T07:25:57-07:00Optimizing Treatment Strategies for Gastric Cancer with Positive Peritoneal Cytology or Localized Peritoneal Metastasis https://news.medxy.ai/ja/predicting-postpartum-hypertension-risk/Medxy AIja2026-10-22T07:25:04-07:00出産後女性の10年高血圧リスクを予測する：人口ベースコホート研究からの知見 https://news.medxy.ai/vi/10-year-postpartum-hypertension-risk-prediction/Medxy AIvi2026-10-22T07:24:45-07:00Dự báo nguy cơ tăng huyết áp 10 năm ở phụ nữ sau sinh: phát hiện từ nghiên cứu đoàn hệ dựa trên quần thể https://news.medxy.ai/predicting-10-year-risk-of-hypertension-in-women-post-pregnancy-insights-from-a-population-based-cohort-study/Medxy AIen2026-10-22T07:24:27-07:00Predicting 10-Year Risk of Hypertension in Women Post-Pregnancy: Insights from a Population-Based Cohort Study https://news.medxy.ai/ja/adjunctive-hypothermia-thrombectomy/Medxy AIja2026-10-22T07:23:34-07:00機械的血栓回収療法中の補助的全身低体温：ReCCLAIM II試験からみた実施可能性と臨床的示唆 https://news.medxy.ai/vi/therapeutic-hypothermia-thrombectomy/Medxy AIvi2026-10-22T07:23:11-07:00Hạ thân nhiệt toàn thân hỗ trợ trong lấy huyết khối cơ học: tính khả thi và những nhận định lâm sàng từ thử nghiệm ReCCLAIM II https://news.medxy.ai/adjuvant-systemic-hypothermia-during-mechanical-thrombectomy-feasibility-and-clinical-insights-from-the-recclaim-ii-trial/Medxy AIen2026-10-22T07:22:53-07:00Adjuvant Systemic Hypothermia During Mechanical Thrombectomy: Feasibility and Clinical Insights from the ReCCLAIM II Trial https://news.medxy.ai/zh/radiofrequency-ablation-calcified-thyroid-cancer/Medxy AIzh2026-10-22T07:22:13-07:00射频消融治疗钙化性乳头状甲状腺微小癌：长期疗效与钙化演变 https://news.medxy.ai/ja/radiofrequency-ablation-thyroid-microcarcinoma/Medxy AIja2026-10-22T07:21:54-07:00石灰化を伴う甲状腺乳頭微小癌に対する高周波焼灼療法：長期成績と石灰化動態 https://news.medxy.ai/vi/long-term-outcomes-thyroid-cancer-ablation/Medxy AIvi2026-10-22T07:21:32-07:00Kết quả dài hạn và diễn tiến vôi hóa sau đốt sóng cao tần ung thư biểu mô tuyến giáp dạng nhú vi thể có vôi hóa https://news.medxy.ai/long-term-outcomes-and-calcification-dynamics-after-radiofrequency-ablation-of-calcified-papillary-thyroid-microcarcinomas/Medxy AIen2026-10-22T07:21:14-07:00Long-Term Outcomes and Calcification Dynamics After Radiofrequency Ablation of Calcified Papillary Thyroid Microcarcinomas https://news.medxy.ai/zh/dilated-cardiomyopathy-arrhythmia-risk/Medxy AIzh2026-10-22T07:20:39-07:00扩张型心肌病的基因型与心律失常风险：遗传分层及临床意义的综合综述 https://news.medxy.ai/ja/dilated-cardiomyopathy-arrhythmia-risk-2/Medxy AIja2026-10-22T07:20:16-07:00拡張型心筋症における遺伝子型と不整脈リスク：遺伝学的層別化と臨床的含意の統合的レビュー https://news.medxy.ai/vi/genotype-arrhythmia-risk-dilated-cardiomyopathy/Medxy AIvi2026-10-22T07:19:49-07:00Kiểu gen và nguy cơ loạn nhịp trong bệnh cơ tim giãn: Tổng quan tích hợp về phân tầng di truyền và ý nghĩa lâm sàng https://news.medxy.ai/genotype-and-arrhythmic-risk-in-dilated-cardiomyopathy-an-integrative-review-of-genetic-stratification-and-clinical-implications/Medxy AIen2026-10-22T07:19:24-07:00Genotype and Arrhythmic Risk in Dilated Cardiomyopathy: An Integrative Review of Genetic Stratification and Clinical Implications https://news.medxy.ai/zh/let-safety-and-gait-outcomes/Medxy AIzh2026-10-22T07:18:39-07:00儿童前交叉韧带重建中加做LET的安全性与步态结局：来自运动分析的证据 https://news.medxy.ai/ja/safety-and-gait-impact-of-lateral-extra-articular-tenodesis/Medxy AIja2026-10-22T07:18:18-07:00小児ACL再建における外側関節外テノデーシス追加の安全性と歩行への影響：動作解析からの示唆 https://news.medxy.ai/vi/let-for-pediatric-acl-reconstruction/Medxy AIvi2026-10-22T07:17:57-07:00Bổ sung LET trong tái tạo dây chằng chéo trước ở trẻ em: độ an toàn và ảnh hưởng lên dáng đi https://news.medxy.ai/safety-and-gait-outcomes-of-adding-lateral-extra-articular-tenodesis-in-pediatric-acl-reconstruction-motion-analysis-insights/Medxy AIen2026-10-22T07:17:37-07:00Safety and Gait Outcomes of Adding Lateral Extra-articular Tenodesis in Pediatric ACL Reconstruction: Motion Analysis Insights https://news.medxy.ai/zh/factors-in-spinal-cord-recovery/Medxy AIzh2026-10-22T07:17:01-07:00创伤性脊髓损伤后功能恢复受哪些因素影响？——6个月随访研究揭示年龄、韧性与健康素养的作用 https://news.medxy.ai/ja/spinal-injury-recovery-factors/Medxy AIja2026-10-22T07:16:42-07:00外傷性脊髄損傷後の機能回復を左右する年齢・レジリエンス・社会的支援・保健医療リテラシー：6か月追跡研究からの示唆 https://news.medxy.ai/vi/factors-affecting-recovery/Medxy AIvi2026-10-22T07:16:20-07:00Tuổi, khả năng phục hồi tâm lý, hỗ trợ xã hội và hiểu biết về sức khỏe ảnh hưởng thế nào đến hồi phục chức năng sau chấn thương tủy sống? Kết quả từ nghiên cứu theo dõi 6 tháng https://news.medxy.ai/influence-of-age-resilience-social-support-and-health-literacy-on-functional-recovery-following-traumatic-spinal-cord-injury-insights-from-a-6-month-follow-up-study/Medxy AIen2026-10-22T07:15:59-07:00Influence of Age, Resilience, Social Support, and Health Literacy on Functional Recovery Following Traumatic Spinal Cord Injury: Insights from a 6-Month Follow-up Study https://news.medxy.ai/zh/universal-adhesive-3-year-performance/Medxy AIzh2026-10-22T07:15:22-07:00OCT评估下通用型黏合剂三年临床表现：选择性釉质酸蚀模式更具优势 https://news.medxy.ai/ja/universal-adhesive-clinical-results/Medxy AIja2026-10-22T07:15:01-07:00OCTで検証するユニバーサル接着材の3年間臨床成績 https://news.medxy.ai/vi/3-year-clinical-evaluation-oct/Medxy AIvi2026-10-22T07:14:39-07:00Đánh giá lâm sàng 3 năm về hiệu quả của chất kết dính đa năng bằng OCT https://news.medxy.ai/three-year-clinical-evaluation-of-universal-adhesive-performance-using-optical-coherence-tomography/Medxy AIen2026-10-22T07:14:22-07:00Three-Year Clinical Evaluation of Universal Adhesive Performance Using Optical Coherence Tomography https://news.medxy.ai/zh/orforglipron-cardiovascular-safety-in-t2dm/Medxy AIzh2026-10-22T07:13:46-07:00Orforglipron 在 2 型糖尿病中的心血管安全性和治疗潜力：来自 ACHIEVE-4 3 期试验的发现 https://news.medxy.ai/ja/orforglipron-cardiovascular-safety/Medxy AIja2026-10-22T07:13:25-07:002型糖尿病におけるorforglipronの心血管安全性と治療可能性：ACHIEVE-4第3相試験からの知見 https://news.medxy.ai/vi/orforglipron-insulin-glargine-diabetes/Medxy AIvi2026-10-22T07:12:59-07:00Orforglipron và insulin glargine ở đái tháo đường típ 2 nguy cơ tim mạch cao: phân tích từ thử nghiệm giai đoạn 3 ACHIEVE-4 https://news.medxy.ai/cardiovascular-safety-and-therapeutic-potential-of-orforglipron-versus-insulin-glargine-in-type-2-diabetes-with-elevated-cardiovascular-risk/Medxy AIen2026-10-22T07:12:38-07:00Cardiovascular Safety and Therapeutic Potential of Orforglipron Versus Insulin Glargine in Type 2 Diabetes with Elevated Cardiovascular Risk: Insights from the ACHIEVE-4 Phase 3 Trial https://news.medxy.ai/an-adolescent-with-neurosyphilis/Medxy AIen2026-10-22T07:11:54-07:00An Adolescent With Neurosyphilis https://news.medxy.ai/rethinking-warm-ischemic-time-limits-in-dcd-organ-donation-insights-from-italys-extended-no-touch-period-experience/Medxy AIen2026-10-22T07:10:07-07:00Rethinking Warm Ischemic Time Limits in DCD Organ Donation: Insights from Italy’s Extended No-touch Period Experience https://news.medxy.ai/zh/low-dose-capecitabine-treatment/Medxy AIzh2026-10-22T07:09:26-07:00长期低剂量卡培他滨治疗难治性皮肤场癌变的疗效与耐受性：一项回顾性队列研究的启示 https://news.medxy.ai/ja/capecitabine-skin-cancer/Medxy AIja2026-10-22T07:09:10-07:00難治性皮膚 field cancerization に対する長期低用量カペシタビンの有効性と忍容性：後ろ向きコホート研究からの知見 https://news.medxy.ai/vi/low-dose-capecitabine-therapy/Medxy AIvi2026-10-22T07:08:50-07:00Capecitabine liều thấp, dùng dài hạn: Hiệu quả và khả năng dung nạp trong field cancerization da kháng trị https://news.medxy.ai/efficacy-and-tolerability-of-long-term-low-dose-capecitabine-for-refractory-cutaneous-field-cancerization-insights-from-a-retrospective-cohort-study/Medxy AIen2026-10-22T07:08:35-07:00Efficacy and Tolerability of Long-Term Low-Dose Capecitabine for Refractory Cutaneous Field Cancerization: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/anxiety-depression-rhinoplasty-outcomes/Medxy AIzh2026-10-22T07:08:02-07:00焦虑与抑郁对功能性及美容性鼻整形术后患者报告结局的影响 https://news.medxy.ai/ja/anxiety-depression-rhinoplasty-outcome/Medxy AIja2026-10-22T07:07:46-07:00機能的および美容的鼻形成術における、不安と抑うつが患者報告アウトカムに及ぼす影響 https://news.medxy.ai/vi/anxiety-depression-surgical-outcomes/Medxy AIvi2026-10-22T07:07:23-07:00Ảnh hưởng của lo âu và trầm cảm đến kết quả do bệnh nhân tự báo cáo sau phẫu thuật chỉnh hình mũi chức năng và thẩm mỹ https://news.medxy.ai/impact-of-anxiety-and-depression-on-patient-reported-outcomes-after-functional-and-aesthetic-rhinoplasty/Medxy AIen2026-10-22T07:07:06-07:00Impact of Anxiety and Depression on Patient-Reported Outcomes After Functional and Aesthetic Rhinoplasty https://news.medxy.ai/zh/gender-differences-in-schizophrenia-treatment/Medxy AIzh2026-10-22T07:06:32-07:00急性精神分裂症中抗精神病治疗结局的性别差异：有何不同？ https://news.medxy.ai/ja/gender-in-schizophrenia-treatment/Medxy AIja2026-10-22T07:06:13-07:00急性統合失調症における抗精神病薬治療の転帰における性差：何が異なるのか？ https://news.medxy.ai/vi/gender-differences-in-schizophrenia/Medxy AIvi2026-10-22T07:05:51-07:00Sự khác biệt về giới tính trong kết quả điều trị bằng thuốc chống loạn thần đối với bệnh tâm thần phân liệt giai đoạn cấp: Những điểm khác biệt là gì? https://news.medxy.ai/understanding-sex-differences-in-antipsychotic-treatment-outcomes-for-acute-schizophrenia/Medxy AIen2026-10-22T07:05:32-07:00Understanding Sex Differences in Antipsychotic Treatment Outcomes for Acute Schizophrenia https://news.medxy.ai/zh/optimizing-high-flow-weaning/Medxy AIzh2026-10-22T07:04:56-07:00危重成人高流量鼻导管撤机策略如何优化？多中心随机试验带来新证据 https://news.medxy.ai/ja/optimizing-high-flow-nasal-cannula-weaning/Medxy AIja2026-10-22T07:04:37-07:00重症成人における高流量鼻カニューレ離脱の最適化：多施設ランダム化試験からの示唆 https://news.medxy.ai/vi/high-flow-nasal-cannula-weaning/Medxy AIvi2026-10-22T07:04:17-07:00Tối ưu hóa chiến lược cai Canuyn mũi lưu lượng cao ở người lớn bệnh nặng: Góc nhìn từ một thử nghiệm ngẫu nhiên đa trung tâm https://news.medxy.ai/optimizing-weaning-strategies-from-high-flow-nasal-cannula-in-critically-ill-adults-insights-from-a-multicenter-randomized-trial/Medxy AIen2026-10-22T07:03:59-07:00Optimizing Weaning Strategies from High-Flow Nasal Cannula in Critically Ill Adults: Insights from a Multicenter Randomized Trial https://news.medxy.ai/zh/reassessing-warm-ischemia-limits/Medxy AIzh2026-10-22T05:11:18-07:00重新审视DCD器官捐献中的温缺血时间界限：来自意大利延长无接触期经验的启示 https://news.medxy.ai/ja/warm-ischemia-limits-in-organ-donation/Medxy AIja2026-10-22T05:10:56-07:00循環死後臓器提供における温阻血時間の上限を見直す：イタリアの長時間ノータッチ期間から得られた知見 https://news.medxy.ai/vi/reassessing-warm-ischemia-limit/Medxy AIvi2026-10-22T05:10:30-07:00Xem xét lại các giới hạn về thời gian thiếu máu cục bộ ấm trong hiến tạng từ người hiến sau khi tim ngừng đập (DCD) https://news.medxy.ai/zh/decoding-ras-mutations-in-acute-myeloid-leukemia/Medxy AIzh2026-10-22T04:49:37-07:00解码急性髓系白血病中RAS突变的基因组与临床影响 https://news.medxy.ai/ja/ras-mutations-aml/Medxy AIja2026-10-22T04:49:17-07:00急性骨髄性白血病におけるRAS変異のゲノム学的・臨床的意義を読み解く https://news.medxy.ai/vi/decoding-ras-mutations-in-aml/Medxy AIvi2026-10-22T04:48:54-07:00Giải mã các ý nghĩa về mặt bộ gen và lâm sàng của các đột biến RAS trong bệnh bạch cầu cấp dòng tủy https://news.medxy.ai/decoding-the-genomic-and-clinical-impact-of-ras-mutations-in-acute-myeloid-leukemia/Medxy AIen2026-10-22T04:48:33-07:00Decoding the Genomic and Clinical Impact of RAS Mutations in Acute Myeloid Leukemia https://news.medxy.ai/ja/antibiotic-duration-consensus/Medxy AIja2026-10-22T04:42:45-07:00短いほどよいことも多い：敗血症とICU重症感染症における抗菌薬投与期間の専門家コンセンサス https://news.medxy.ai/vi/shorter-antibiotic-treatment/Medxy AIvi2026-10-22T04:42:08-07:00Rút ngắn liệu trình kháng sinh: Đồng thuận chuyên gia về thời gian điều trị trong nhiễm khuẩn huyết và nhiễm trùng nặng tại ICU https://news.medxy.ai/zh/shorter-antibiotic-courses-sepsis/Medxy AIzh2026-10-22T04:41:33-07:00脓毒症与ICU重症感染抗生素疗程：专家共识为何更偏向“更短” https://news.medxy.ai/shorter-is-often-better-expert-consensus-on-antibiotic-duration-in-sepsis-and-severe-infections-in-the-icu/Medxy AIen2026-10-22T04:41:06-07:00Shorter Is Often Better: Expert Consensus on Antibiotic Duration in Sepsis and Severe Infections in the ICU https://news.medxy.ai/zh/routine-vaccination-for-uveitis-prevention/Medxy AIzh2026-10-22T04:40:01-07:00定期预防接种能否抑制特发性葡萄膜炎的发病：免疫调节与临床启示 https://news.medxy.ai/ja/routine-vaccination-uveitis-prevention/Medxy AIja2026-10-22T04:39:40-07:00定期予防接種は特発性ぶどう膜炎の発症を抑えるか：免疫調節と臨床的示唆 https://news.medxy.ai/vi/routine-vaccine-uveitis-prevention/Medxy AIvi2026-10-22T04:39:12-07:00Tiêm chủng định kỳ có giúp ngăn ngừa khởi phát viêm màng bồ đào vô căn không: Điều hòa miễn dịch và các gợi ý lâm sàng https://news.medxy.ai/associations-between-routine-vaccinations-and-the-risk-of-new-onset-idiopathic-uveitis-immune-modulation-and-clinical-implications/Medxy AIen2026-10-22T04:38:48-07:00Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis: Immune Modulation and Clinical Implications https://news.medxy.ai/zh/electrostimulation-bells-palsy-recovery/Medxy AIzh2026-10-22T04:38:01-07:00贝尔麻痹恢复中电刺激的阶段性影响：早期过度使用的风险与慢性后遗症期的获益 https://news.medxy.ai/vi/electrical-stimulation-bells-palsy/Medxy AIvi2026-10-22T04:37:21-07:00Kích thích điện trong liệt Bell: lợi ích theo giai đoạn và nguy cơ khi dùng sớm quá mức https://news.medxy.ai/phase-dependent-effects-of-electrical-stimulation-on-bells-palsy-recovery-risks-of-early-overuse-and-benefits-in-chronic-sequelae/Medxy AIen2026-10-22T04:37:04-07:00Phase-Dependent Effects of Electrical Stimulation on Bell’s Palsy Recovery: Risks of Early Overuse and Benefits in Chronic Sequelae https://news.medxy.ai/zh/kidney-transplant-reform-seti/Medxy AIzh2026-10-22T04:36:29-07:00变革肾移植的改革：SETI 提升可及性与效率 https://news.medxy.ai/ja/kidney-transplant-reform/Medxy AIja2026-10-22T04:36:09-07:00腎移植を変える運用改革：SETIがアクセスと効率を高める https://news.medxy.ai/vi/kidney-transplant-care-innovation/Medxy AIvi2026-10-22T04:35:46-07:00Đổi mới chăm sóc ghép thận: Tái thiết kế vận hành SETI giúp tăng khả năng tiếp cận và hiệu quả https://news.medxy.ai/transforming-kidney-transplant-care-the-seti-operational-redesign-enhances-access-and-efficiency/Medxy AIen2026-10-22T04:35:25-07:00Transforming Kidney Transplant Care: The SETI Operational Redesign Enhances Access and Efficiency https://news.medxy.ai/zh/recurrent-implantation-failure/Medxy AIzh2026-10-22T04:34:50-07:00破解复发性种植失败：HSP70介导的巨噬细胞-基质细胞串扰在子宫内膜失调中的作用 https://news.medxy.ai/ja/decoding-implantation-failure/Medxy AIja2026-10-22T04:34:31-07:00反復着床不全の謎を解く：子宮内膜異常におけるHSP70媒介マクロファージ―間質細胞相互作用の役割 https://news.medxy.ai/vi/recurrent-implantation-failure-2/Medxy AIvi2026-10-22T04:34:04-07:00Giải mã thất bại làm tổ tái diễn: Vai trò của crosstalk giữa đại thực bào và tế bào mô đệm qua HSP70 trong rối loạn nội mạc tử cung https://news.medxy.ai/decoding-recurrent-implantation-failure-the-role-of-hsp70-mediated-macrophage-stromal-crosstalk-in-endometrial-dysregulation/Medxy AIen2026-10-22T04:33:43-07:00Decoding Recurrent Implantation Failure: The Role of HSP70-Mediated Macrophage-Stromal Crosstalk in Endometrial Dysregulation https://news.medxy.ai/ja/aasld-expo-2026-liver-biopsy-guidelines/Medxy AIja2026-10-22T04:33:09-07:00AASLD EXPO 2026：肝生検の現代的役割と推奨 https://news.medxy.ai/vi/modern-liver-biopsy-guidelines/Medxy AIvi2026-10-22T04:32:35-07:00AASLD EXPO 2026: Vai trò hiện đại và khuyến nghị về sinh thiết gan https://news.medxy.ai/zh/aasld-expo-2026-liver-biopsy/Medxy AIzh2026-10-22T04:31:59-07:00AASLD EXPO 2026：肝活检的现代价值与临床建议 https://news.medxy.ai/aasld-expo-2026-modern-role-and-recommendations-for-liver-biopsy/Medxy AIen2026-10-22T04:31:31-07:00AASLD EXPO 2026: Modern Role and Recommendations for Liver Biopsy https://news.medxy.ai/zh/blood-biomarkers-alzheimers-cognitive-decline/Medxy AIzh2026-10-22T04:30:36-07:00中晚年血液生物标志物能否预示阿尔茨海默病与长期认知衰退？ https://news.medxy.ai/ja/blood-biomarkers-in-alzheimers-cognitive-decline/Medxy AIja2026-10-22T04:30:13-07:00中高年期の血液バイオマーカーは、アルツハイマー病や長期的な認知機能低下を予測できるか？ https://news.medxy.ai/vi/blood-biomarkers-alzheimers-risk-2/Medxy AIvi2026-10-22T04:29:51-07:00Dấu ấn sinh học máu ở tuổi trung niên và tuổi già có thể dự báo bệnh Alzheimer và suy giảm nhận thức dài hạn như thế nào https://news.medxy.ai/blood-biomarkers-alzheimers-risk/Medxy AIen2026-10-22T04:29:31-07:00Predictive Value of Midlife and Late-Life Blood Biomarkers for Alzheimer’s Disease and Long-Term Cognitive Decline https://news.medxy.ai/zh/12-13-dihome-prognostic-biomarker/Medxy AIzh2026-10-21T07:28:57-07:0012,13-diHOME：心搏骤停后靶向体温管理中棕色脂肪激活与预后的潜在标志物 https://news.medxy.ai/ja/dihome-biomarker-outcomes/Medxy AIja2026-10-21T07:28:35-07:0012,13-diHOME高値は心停止後TTMにおける褐色脂肪組織活性化と良好転帰の指標となりうる https://news.medxy.ai/vi/dihome-cardiac-arrest-temperature-control/Medxy AIvi2026-10-21T07:28:11-07:0012,13-diHOME: Dấu ấn tiềm năng của hoạt hóa mô mỡ nâu và tiên lượng trong kiểm soát thân nhiệt sau ngừng tim https://news.medxy.ai/1213-dihome-levels-as-a-marker-of-brown-adipose-tissue-activation-and-outcome-in-targeted-temperature-management-post-cardiac-arrest/Medxy AIen2026-10-21T07:27:47-07:0012,13-diHOME Levels as a Marker of Brown Adipose Tissue Activation and Outcome in Targeted Temperature Management Post-Cardiac Arrest https://news.medxy.ai/zh/encircle-tmvr-outcomes/Medxy AIzh2026-10-21T07:27:10-07:00SAPIEN M3 经房间隔 TMVR：ENCIRCLE MAC 注册研究二尖瓣瓣环钙化患者 1 年结局 https://news.medxy.ai/ja/transseptal-tmvr-mac-registry/Medxy AIja2026-10-21T07:26:48-07:00SAPIEN M3システムによる経中隔TMVR：ENCIRCLE MAC Registryが示した僧帽弁輪石灰化患者の1年成績 https://news.medxy.ai/vi/one-year-outcomes-sapien-m3-transseptal-mitral-valve-replacement/Medxy AIvi2026-10-21T07:26:25-07:00Kết quả 1 năm của thay van hai lá qua vách liên nhĩ bằng hệ thống SAPIEN M3 ở bệnh nhân vôi hóa vòng van hai lá từ sổ đăng ký ENCIRCLE MAC https://news.medxy.ai/transseptal-tmvr-using-the-sapien-m3-system-1-year-outcomes-in-patients-with-mitral-annular-calcification-from-the-encircle-mac-registry/Medxy AIen2026-10-21T07:26:05-07:00Transseptal TMVR Using the SAPIEN M3 System: 1-Year Outcomes in Patients with Mitral Annular Calcification from the ENCIRCLE MAC Registry https://news.medxy.ai/zh/high-impact-activity-arthritis-risk/Medxy AIzh2026-10-21T07:25:30-07:00高冲击体力活动会影响髋、膝骨关节炎的关节置换风险吗？一项大规模纵向中介研究 https://news.medxy.ai/ja/high-impact-exercise-joint-replacement-risk/Medxy AIja2026-10-21T07:25:07-07:00股関節・膝OAにおける高衝撃運動と関節置換リスク：大規模縦断媒介分析 https://news.medxy.ai/vi/high-impact-activity-joint-replacement/Medxy AIvi2026-10-21T07:24:42-07:00Hoạt động thể chất cường độ tác động mạnh và nguy cơ thay khớp ở thoái hóa khớp háng, gối: một nghiên cứu dọc quy mô lớn về vai trò trung gian https://news.medxy.ai/high-impact-physical-activity-and-joint-replacement-risk-in-hip-and-knee-osteoarthritis-a-large-scale-longitudinal-mediation-study/Medxy AIen2026-10-21T07:24:21-07:00High-Impact Physical Activity and Joint Replacement Risk in Hip and Knee Osteoarthritis: A Large-Scale Longitudinal Mediation Study https://news.medxy.ai/zh/emergency-surgery-recovery/Medxy AIzh2026-10-21T07:23:44-07:00急诊腹部手术后，综合呼吸与功能训练可促进撤机并加速恢复：来自随机对照试验的启示 https://news.medxy.ai/ja/accelerated-recovery-training/Medxy AIja2026-10-21T07:23:25-07:00呼吸・機能訓練の統合で離脱と回復を加速：緊急開腹手術RCTからの示唆 https://news.medxy.ai/vi/respiratory-training-ventilator-weaning/Medxy AIvi2026-10-21T07:23:02-07:00Kết hợp huấn luyện hô hấp và chức năng giúp tăng tỷ lệ cai máy thở và phục hồi sau phẫu thuật bụng cấp cứu: Góc nhìn từ một thử nghiệm đối chứng ngẫu nhiên https://news.medxy.ai/integrated-respiratory-and-functional-training-enhances-weaning-and-recovery-after-emergency-abdominal-surgery-insights-from-a-randomized-controlled-trial/Medxy AIen2026-10-21T07:22:43-07:00Integrated Respiratory and Functional Training Enhances Weaning and Recovery After Emergency Abdominal Surgery: Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/peri-implant-soft-tissue-enhancement/Medxy AIzh2026-10-21T07:22:05-07:00优化种植体周围软组织维度：骨嵴软组织增量的时机与材料选择 https://news.medxy.ai/ja/optimizing-implant-tissue-enhancement/Medxy AIja2026-10-21T07:21:41-07:00歯槽頂部軟組織増大の最適化：インプラント周囲組織を高める時期と材料 https://news.medxy.ai/vi/implant-soft-tissue-augmentation/Medxy AIvi2026-10-21T07:21:14-07:00Tối ưu hóa kích thước mô quanh implant: Thời điểm và vật liệu trong tăng cường mô mềm vùng mào https://news.medxy.ai/optimizing-peri-implant-tissue-dimensions-timing-and-materials-in-crestal-soft-tissue-augmentation/Medxy AIen2026-10-21T07:20:54-07:00Optimizing Peri-Implant Tissue Dimensions: Timing and Materials in Crestal Soft-Tissue Augmentation https://news.medxy.ai/zh/ponatinib-blinatumomab-vs-imatinib-chemo/Medxy AIzh2026-10-21T07:20:17-07:00Ponatinib 联合 Blinatumomab 对比 Imatinib 联合化疗：推进成人 Philadelphia 染色体阳性 ALL 的一线治疗 https://news.medxy.ai/ja/ponatinib-blinatumomab-vs-imatinib-chemotherapy/Medxy AIja2026-10-21T07:19:56-07:00ponatinib＋blinatumomabはimatinib＋化学療法を上回るのか――成人Ph陽性ALLの一次治療を変える第3相試験 https://news.medxy.ai/vi/ponatinib-blinatumomab-all-treatment/Medxy AIvi2026-10-21T07:19:33-07:00Ponatinib phối hợp Blinatumomab so với Imatinib và Hóa trị: Bước tiến trong điều trị tuyến đầu ALL dương tính với Philadelphia ở người lớn https://news.medxy.ai/ponatinib-plus-blinatumomab-vs-imatinib-and-chemotherapy-advancing-frontline-therapy-in-adult-philadelphia-positive-all/Medxy AIen2026-10-21T07:19:13-07:00Ponatinib Plus Blinatumomab vs. Imatinib And Chemotherapy: Advancing Frontline Therapy in Adult Philadelphia-Positive ALL https://news.medxy.ai/zh/explainable-ai-oct-outcome-prediction/Medxy AIzh2026-10-21T07:15:41-07:00用可解释AI驱动的OCT生物标志物预测中心性浆液性脉络膜视网膜病变结局：来自多中心队列研究的启示 https://news.medxy.ai/ja/interpretable-ai-retinopathy-prognosis/Medxy AIja2026-10-21T07:15:24-07:00解釈可能AIで読み解く中心性漿液性脈絡網膜症の予後予測：多施設コホート研究からの知見 https://news.medxy.ai/vi/central-serous-retinopathy-prediction/Medxy AIvi2026-10-21T07:15:01-07:00Dự đoán diễn tiến bệnh lý hắc võng mạc trung tâm thanh dịch bằng AI có khả năng diễn giải từ biomarker OCT: Kết quả từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/predicting-central-serous-chorioretinopathy-outcomes-using-interpretable-ai-driven-oct-biomarkers-insights-from-a-multicenter-cohort-study/Medxy AIen2026-10-21T07:14:43-07:00Predicting Central Serous Chorioretinopathy Outcomes Using Interpretable AI-Driven OCT Biomarkers: Insights from a Multicenter Cohort Study https://news.medxy.ai/zh/facial-synkinesis-phenotypes/Medxy AIzh2026-10-21T07:14:03-07:00面部联动异常静息期表型分层：对手术规划的启示 https://news.medxy.ai/ja/facial-synkinesis-phenotype/Medxy AIja2026-10-21T07:13:44-07:00顔面連合運動の静止時表現型を読み解く：外科計画への示唆 https://news.medxy.ai/vi/resting-facial-synergies/Medxy AIvi2026-10-21T07:13:15-07:00Ba kiểu hình đồng vận mặt lúc nghỉ: Gợi ý quan trọng cho lập kế hoạch phẫu thuật https://news.medxy.ai/phenotypic-stratification-of-facial-synkinesis-resting-states-implications-for-surgical-planning/Medxy AIen2026-10-21T07:13:00-07:00Phenotypic Stratification of Facial Synkinesis Resting States: Implications for Surgical Planning https://news.medxy.ai/zh/acute-normovolemic-hemodilution-safety/Medxy AIzh2026-10-21T07:12:20-07:00女性心脏手术中急性等容性稀释的效果与安全性：血液保护策略是否仍需调整？ https://news.medxy.ai/ja/reassessing-acute-normovolemic-hemodilution/Medxy AIja2026-10-21T07:12:03-07:00女性の心臓手術における急性等容量血液希釈を再検証：有効性・安全性・臨床的意義 https://news.medxy.ai/vi/acute-isovolemic-hemodilution-heart-surgery/Medxy AIvi2026-10-21T07:11:40-07:00Trích máu pha loãng đẳng tích cấp tính ở phụ nữ phẫu thuật tim: Hiệu quả, độ an toàn và ý nghĩa lâm sàng https://news.medxy.ai/evaluating-acute-normovolemic-hemodilution-in-women-undergoing-cardiac-surgery-efficacy-safety-and-clinical-implications/Medxy AIen2026-10-21T07:11:23-07:00Evaluating Acute Normovolemic Hemodilution in Women Undergoing Cardiac Surgery: Efficacy, Safety, and Clinical Implications https://news.medxy.ai/zh/postpartum-blood-pressure-monitoring/Medxy AIzh2026-10-21T07:10:46-07:00产后 6 周血压监测：可预测妊娠期高血压女性的长期心血管风险 https://news.medxy.ai/ja/postpartum-blood-pressure-monitoring-3/Medxy AIja2026-10-21T07:10:26-07:00妊娠高血圧性疾患後の産後血圧モニタリングが将来の心血管リスクを予測する https://news.medxy.ai/vi/postpartum-blood-pressure-monitoring-2/Medxy AIvi2026-10-21T07:10:06-07:00Theo dõi huyết áp sau sinh ở phụ nữ có rối loạn tăng huyết áp thai kỳ dự báo nguy cơ tim mạch lâu dài https://news.medxy.ai/postpartum-blood-pressure-monitoring-after-hypertensive-disorders-of-pregnancy-predicts-long-term-cardiovascular-risk/Medxy AIen2026-10-21T07:09:47-07:00Postpartum Blood Pressure Monitoring After Hypertensive Disorders of Pregnancy Predicts Long-Term Cardiovascular Risk https://news.medxy.ai/zh/saroglitazar-pcos-masld-hope/Medxy AIzh2026-10-21T07:09:09-07:00Saroglitazar为PCOS合并MASLD女性的肝脂肪变性治疗带来新希望：一项多中心试验的启示 https://news.medxy.ai/ja/saroglitazar-pcos-liver-fat/Medxy AIja2026-10-21T07:08:46-07:00PCOS合併MASLD女性の肝脂肪化にSaroglitazarが有望：多施設共同試験からの知見 https://news.medxy.ai/vi/saroglitazar-pcos-masld-trial/Medxy AIvi2026-10-21T07:08:26-07:00Saroglitazar cho thấy triển vọng trong điều trị gan nhiễm mỡ ở phụ nữ mắc PCOS và MASLD: Góc nhìn từ một thử nghiệm đa trung tâm https://news.medxy.ai/saroglitazar-shows-promise-in-treating-hepatic-steatosis-in-women-with-pcos-and-masld-insights-from-a-multicenter-trial/Medxy AIen2026-10-21T07:08:10-07:00Saroglitazar Shows Promise in Treating Hepatic Steatosis in Women with PCOS and MASLD: Insights from a Multicenter Trial https://news.medxy.ai/zh/infections-alzheimers-neuropathologyorrelation/Medxy AIzh2026-10-21T07:07:33-07:00常见感染与阿尔茨海默病神经病理之间有何关联？——来自英国前瞻性队列研究的启示 https://news.medxy.ai/ja/common-infections-alzheimers-link/Medxy AIja2026-10-21T07:07:14-07:00一般的感染症とアルツハイマー病神経病理の関連を探る：英国前向きコホート研究からの知見 https://news.medxy.ai/vi/common-infections-alzheimers-link-2/Medxy AIvi2026-10-21T07:06:51-07:00Khám phá mối liên hệ giữa các nhiễm trùng thường gặp và bệnh lý thần kinh Alzheimer: Góc nhìn từ một nghiên cứu đoàn hệ tiến cứu tại Vương quốc Anh https://news.medxy.ai/infections-alzheimers-link/Medxy AIen2026-10-21T07:05:28-07:00Exploring the Link Between Common Infections and Alzheimer’s Disease Neuropathology: Insights From a UK Prospective Cohort Study https://news.medxy.ai/ja/heart-failure-definition-2026-3/Medxy AIja2026-10-21T07:04:45-07:00心不全の「第2版国際定義」2026年版：AHA/ACC/ESC/WHFコンセンサスの主要変更点と臨床への示唆 https://news.medxy.ai/vi/aha-heart-failure-definition/Medxy AIvi2026-10-21T07:04:15-07:00“Định nghĩa quốc tế về suy tim – Phiên bản thứ 2” (năm 2026): Những thay đổi chính trong sự đồng thuận của AHA/ACC/ESC/WHF và ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/zh/heart-failure-definition-2026-2/Medxy AIzh2026-10-21T07:03:43-07:002026版心力衰竭第二次统一定义：AHA/ACC/ESC/WHF专家共识的关键变化与临床要点 https://news.medxy.ai/second-universal-definition-of-heart-failure-2026-key-changes-and-clinical-guidance-from-the-aha-acc-esc-whf-expert-consensus/Medxy AIen2026-10-21T07:03:08-07:00Second Universal Definition of Heart Failure (2026): Key Changes and Clinical Guidance from the AHA/ACC/ESC/WHF Expert Consensus https://news.medxy.ai/zh/msi-high-gastric-cancer-immunotherapy/Medxy AIzh2026-10-21T07:02:10-07:00MSI-high 胃癌与胃食管结合部腺癌新辅助 nivolumab 联合 ipilimumab 的长期疗效：来自 NEONIPIGA 2 期试验的启示 https://news.medxy.ai/ja/neoadjuvant-immunotherapy-gastric-cancer/Medxy AIja2026-10-21T07:01:49-07:00MSI-high胃・胃食道接合部腺癌に対するニボルマブ／イピリムマブ術前療法の長期成績：第2相NEONIPIGA試験からの知見 https://news.medxy.ai/vi/long-term-outcomes-immunotherapy-gastric-cancer/Medxy AIvi2026-10-21T07:01:27-07:00Kết cục dài hạn của nivolumab và ipilimumab trước phẫu thuật trong ung thư biểu mô tuyến dạ dày và GEJ MSI-high: Góc nhìn từ thử nghiệm pha 2 NEONIPIGA https://news.medxy.ai/long-term-outcomes-of-neoadjuvant-nivolumab-and-ipilimumab-in-msi-high-gastric-and-gej-adenocarcinoma-insights-from-the-phase-2-neonipiga-trial/Medxy AIen2026-10-21T07:01:10-07:00Long-term Outcomes of Neoadjuvant Nivolumab and Ipilimumab in MSI-High Gastric and GEJ Adenocarcinoma: Insights from the Phase 2 NEONIPIGA Trial https://news.medxy.ai/zh/alignment-changes-after-acl-reconstruction/Medxy AIzh2026-10-21T07:00:27-07:00接近骨骼成熟期经骨骺前交叉韧带重建后的力线变化：PLUTO研究组的观察 https://news.medxy.ai/ja/alignment-changes-after-acl-reconstruction-3/Medxy AIja2026-10-21T07:00:06-07:00骨成熟直前の経骨端線ACL再建術後に生じるアライメント変化をどう捉えるか——PLUTO Study Groupの知見 https://news.medxy.ai/vi/alignment-changes-after-acl-reconstruction-2/Medxy AIvi2026-10-21T06:59:43-07:00Thay đổi thẳng trục sau tái tạo dây chằng chéo trước xuyên sụn tăng trưởng gần trưởng thành xương: Kinh nghiệm từ nhóm nghiên cứu PLUTO https://news.medxy.ai/navigating-alignment-changes-after-transphyseal-acl-reconstruction-near-skeletal-maturity-insights-from-the-pluto-study-group/Medxy AIen2026-10-21T06:59:25-07:00Navigating Alignment Changes After Transphyseal ACL Reconstruction Near Skeletal Maturity: Insights from the PLUTO Study Group https://news.medxy.ai/zh/pilates-fibromyalgia-rehabilitation/Medxy AIzh2026-10-21T06:58:49-07:00普拉提联合自我筋膜放松：6个月远程监督康复为纤维肌痛管理带来新思路 https://news.medxy.ai/ja/fibromyalgia-management/Medxy AIja2026-10-21T06:58:28-07:00ピラティスと自己筋膜リリースを組み合わせた6か月監督下テレリハビリテーションによる線維筋痛症管理の改善 https://news.medxy.ai/enhanced-fibromyalgia-management-through-six-month-supervised-telerehabilitation-integrating-pilates-and-self-myofascial-release/Medxy AIen2026-10-21T06:57:50-07:00Enhanced Fibromyalgia Management Through Six-Month Supervised Telerehabilitation: Integrating Pilates and Self-Myofascial Release https://news.medxy.ai/digitally-guided-root-membrane-preparation-using-a-dedicated-apex-guide-for-immediate-implant-placement-a-retrospective-case-series/Medxy AIen2026-10-21T06:57:17-07:00Digitally Guided Root Membrane Preparation Using a Dedicated Apex Guide for Immediate Implant Placement: A Retrospective Case Series https://news.medxy.ai/zh/shortened-hepatitis-c-treatment/Medxy AIzh2026-10-21T06:56:39-07:00慢性丙型肝炎无肝硬化患者的索磷布韦/维帕他韦疗程缩短：来自印度 RESOLVE 试验的证据 https://news.medxy.ai/ja/short-course-hepatitis-c-treatment/Medxy AIja2026-10-21T06:56:20-07:00非肝硬変慢性C型肝炎におけるソホスブビル・ベルパタスビル短期治療：インドRESOLVE試験のエビデンス https://news.medxy.ai/vi/shortened-sofosbuvir-velpatasvir-treatment/Medxy AIvi2026-10-21T06:56:01-07:00Rút ngắn điều trị Sofosbuvir-Velpatasvir cho viêm gan C mạn tính không xơ gan: Bằng chứng từ thử nghiệm RESOLVE tại Ấn Độ https://news.medxy.ai/shortening-sofosbuvir-velpatasvir-therapy-for-non-cirrhotic-chronic-hepatitis-c-evidence-from-the-resolve-trial-in-india/Medxy AIen2026-10-21T06:55:44-07:00Shortening Sofosbuvir-Velpatasvir Therapy for Non-Cirrhotic Chronic Hepatitis C: Evidence from the RESOLVE Trial in India https://news.medxy.ai/zh/pediatric-social-risk-screening/Medxy AIzh2026-10-21T06:55:06-07:00儿科住院社会风险筛查与转介实践现状：一项全国调查 https://news.medxy.ai/ja/social-risk-screening-referrals/Medxy AIja2026-10-21T06:54:52-07:00小児入院医療における社会的リスク・スクリーニングと紹介の実態：全国調査 https://news.medxy.ai/vi/social-risk-screening-referrals-2/Medxy AIvi2026-10-21T06:54:27-07:00Sàng lọc nguy cơ xã hội và thực hành chuyển tuyến trong nhi khoa nội trú: Kết quả từ một khảo sát quốc gia https://news.medxy.ai/assessing-social-risk-screening-and-referral-practices-in-pediatric-inpatient-care-a-national-survey/Medxy AIen2026-10-21T06:54:09-07:00Assessing Social Risk Screening and Referral Practices in Pediatric Inpatient Care: A National Survey https://news.medxy.ai/zh/neutrophil-lymphocyte-ratio-skin-cancer/Medxy AIzh2026-10-21T06:43:15-07:00高风险皮肤鳞状细胞癌中中性粒细胞/淋巴细胞比值的预后价值 https://news.medxy.ai/ja/neutrophil-lymphocyte-ratio/Medxy AIja2026-10-21T06:42:55-07:00高リスク皮膚扁平上皮癌における予後バイオマーカーとしての好中球/リンパ球比 https://news.medxy.ai/vi/neutrophil-lymphocyte-ratio-2/Medxy AIvi2026-10-21T06:42:34-07:00Tỷ lệ bạch cầu trung tính/bạch cầu lympho: dấu ấn tiên lượng trong ung thư biểu mô tế bào vảy da nguy cơ cao https://news.medxy.ai/neutrophil-to-lymphocyte-ratio-as-a-prognostic-biomarker-in-high-risk-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-10-21T06:42:14-07:00Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in High-Risk Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/zh/long-term-breast-reduction-lift-results/Medxy AIzh2026-10-21T06:41:35-07:00改良 Liacyr-Ribeiro 技术在乳房缩小与上提中的长期稳定效果 https://news.medxy.ai/ja/breast-reduction-lift-long-term-results/Medxy AIja2026-10-21T06:41:14-07:00乳房縮小・挙上術における改良Liacyr-Ribeiro法の長期的な安定した効果 https://news.medxy.ai/vi/long-term-breast-reduction-lift-results-2/Medxy AIvi2026-10-21T06:40:45-07:00Kết quả lâu dài bền vững của kỹ thuật Modified Liacyr-Ribeiro trong thu nhỏ tuyến vú và nâng tuyến vú https://news.medxy.ai/durable-long-term-outcomes-of-the-modified-liacyr-ribeiro-technique-in-breast-reduction-and-mastopexy/Medxy AIen2026-10-21T06:40:23-07:00Durable Long-Term Outcomes of the Modified Liacyr-Ribeiro Technique in Breast Reduction and Mastopexy